Canada ploughs Can$100 million into global AIDS efforts:
This article was originally published in Clinica
The Canadian government has committed Can$100m (US$72m) over two years to the global initiative to increase access to HIV/AIDS treatment in the developing world. The so-called "3 by 5" programme, led by the World Health Organization, aims to treat three million people living with AIDS by the end of 2005 and has important diagnostic and therapy monitoring components. There are some 34-46 million people infected with HIV worldwide. Only around 400,000, out of an estimated six million people in the developing world, have access to the antiretroviral therapy they need to survive. Every year, around three million people die for lack of such treatment.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.